Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Skvortsov

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Vestnik Rentgenologii I Radiologii|June 12, 2012
[Does percutaneous myocardial revascularization affect the course and prognosis of chronic heart failure?]N V Shashkova, S N Tereshchenko, L E Samoĭlenko, et al.
Terapevticheskii Arkhiv|January 1, 1988
[Use of peripheral vasodilator agents with various mechanisms of action in patients with dilated cardiomyopathy]R A Grigor'iants, V G Naumov, S A Shevliagin, et al.
Terapevticheskii Arkhiv|January 1, 1991
[Atrial natriuretic factor in chronic heart failure]A A Skvortsov, V P Masenko, E A Bosykh, et al.
Kardiologiia|July 31, 2012
[Epidemiology of dilation cardiomyopathy]E N Alaeva, O Iu Narusov, A A Safiulina, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|June 3, 2015
[Hybrid surgical intervention in a patient with an aortic arch aneurysm and coronary artery disease]E R Charchan, S A Abugov, M V Puretsky, et al.
Kardiologiia|March 15, 2017
[Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results]A A Skvortsov, D E Koshkina, O Yu Narusov, et al.
Kardiologiia|February 12, 2008
[Effect of long term therapy with spironolactone on parameters of 24-hour heart rhythm variability and ventricular arrhythmias in patients with heart failure receiving optimal therapy]A A Skvortsov, V Iu Mareev, Ia A Orlova, et al.
Terapevticheskii Arkhiv|October 7, 2005
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)]A A Skvortsov, S N Nasonova, A V Sychev, et al.
Terapevticheskii Arkhiv|September 29, 2010
[Inflammatory cardiomyopathy: state-of-the-art]E A Beliavskiĭ, K A Zykov, O Iu Narusov, et al.
Khirurgiia|June 7, 2019
[Postoperative care in patients with DeBakey type I aortic dissection: criteria of aortic remodeling and risk factors of disease progression]E R Charchyan, S A Abugov, Z R Khachatryan, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Vestnik Rentgenologii I Radiologii|June 12, 2012
[Does percutaneous myocardial revascularization affect the course and prognosis of chronic heart failure?]N V Shashkova, S N Tereshchenko, L E Samoĭlenko, et al.
Terapevticheskii Arkhiv|January 1, 1988
[Use of peripheral vasodilator agents with various mechanisms of action in patients with dilated cardiomyopathy]R A Grigor'iants, V G Naumov, S A Shevliagin, et al.
Terapevticheskii Arkhiv|January 1, 1991
[Atrial natriuretic factor in chronic heart failure]A A Skvortsov, V P Masenko, E A Bosykh, et al.
Kardiologiia|July 31, 2012
[Epidemiology of dilation cardiomyopathy]E N Alaeva, O Iu Narusov, A A Safiulina, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|June 3, 2015
[Hybrid surgical intervention in a patient with an aortic arch aneurysm and coronary artery disease]E R Charchan, S A Abugov, M V Puretsky, et al.
Kardiologiia|March 15, 2017
[Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results]A A Skvortsov, D E Koshkina, O Yu Narusov, et al.
Kardiologiia|February 12, 2008
[Effect of long term therapy with spironolactone on parameters of 24-hour heart rhythm variability and ventricular arrhythmias in patients with heart failure receiving optimal therapy]A A Skvortsov, V Iu Mareev, Ia A Orlova, et al.
Terapevticheskii Arkhiv|October 7, 2005
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)]A A Skvortsov, S N Nasonova, A V Sychev, et al.
Terapevticheskii Arkhiv|September 29, 2010
[Inflammatory cardiomyopathy: state-of-the-art]E A Beliavskiĭ, K A Zykov, O Iu Narusov, et al.
Khirurgiia|June 7, 2019
[Postoperative care in patients with DeBakey type I aortic dissection: criteria of aortic remodeling and risk factors of disease progression]E R Charchyan, S A Abugov, Z R Khachatryan, et al.
Pageof 5